WILLIAMSBURG, Va., Feb. 26 -- William and Mary issued the following news release:
Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy.In a recentBioconjugate Chemistrypublication, William & Mary researchers designed an antibody-drug conjugate (ADC) with the potential to improve the potency and decrease the cost of currently approved cancer drugs.
Like guided missiles carrying warheads, ADCs are designed to seek out cancer cells and hit them with a powerful toxin. Made up of an antibody (the missile's GPS, which homes in on the cancer) and a drug (the payload), they represent a major advancement over traditional non-targeted ...